AE Patient Classification...................................................................................................................... 1

Airborne Spread................................................................................................................................. 1

Ancillary Services.............................................................................................................................. 29

Antibody/Antigen............................................................................................................................... 2

Behavioral Health............................................................................................................................. 27

Cleaning, Disinfecting Households and Facilities................................................................................... 9

Contact Tracing ................................................................................................................................ 38

Critical Resource Conservation.......................................................................................................... 12

Command and Control........................................................................................................................ 4

Communications ................................................................................................................................ 5

Contact Spread................................................................................................................................... 2

Crisis Standards of Care....................................................................................................................... 3

Definitions ......................................................................................................................................... 1

Documentation ................................................................................................................................. 6

Droplet Spread................................................................................................................................... 2

Environmental Services/Housekeeping.............................................................................................. 29

Executive Summary............................................................................................................................ 1

Facilities Management ....................................................................................................................... 8

Field Sanitation and Isolation............................................................................................................. 31

Ethical Considerations....................................................................................................................... 13

Human Resources............................................................................................................................. 18

Hygiene, Social Distancing, Shelter in Place, and General Protection Measures.................................... 17

Infection Prevention and Control (IPC)............................................................................................... 25

Intermediate Care Ward (ICW)............................................................................................................ 2

Laboratory (Screening/Testing) ......................................................................................................... 29

Medical Centers (MEDCENs), Contact Information.............................................................................. 26

Medical Management....................................................................................................................... 24

Mortuary Affairs............................................................................................................................... 28

Operational Planning ......................................................................................................................... 4

Pathogen.......................................................................................................................................... 29

Patient Under Investigation (PUI)........................................................................................................ 2

Performance Improvement ................................................................................................................ 6

Personal Protective Equipment (PPE) Considerations............................................................................ 8

Pharmacy......................................................................................................................................... 29

Quarantine Facilities......................................................................................................................... 10

Radiology......................................................................................................................................... 29

Resiliency/Well-Being....................................................................................................................... 27

Screening/Testing............................................................................................................................. 23

Skills Building/Training...................................................................................................................... 19

Staff (Patient: Staffing Ratios, Resilience/Well-Being).......................................................................... 18

Staff Surveillance and Staffing Decisions............................................................................................. 21

Supplies........................................................................................................................................... 33

Surge Capabilities............................................................................................................................. 11

Suspected, Confirmed Cases ............................................................................................................... 6

Telemedicine/VITAL-T/Points of Contact............................................................................................ 25

Transport........................................................................................................................................... 7

Triage/Security................................................................................................................................. 14